RxDoctor Payments Data

Laura Helm

Medical · Millcreek, UTNPI 1104003656

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,820 of the $3,637 with a category attached, or 77.5%. 33 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 27.0% of the total. Reporting peaked in 2021 at $1,921 and has fallen 96.7% since, to $63 in 2025.

$3,637in general payments, 2019–2025

Across 150 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$981
  • AbbVie$853
  • AstraZeneca$222
  • Boehringer Ingelheim$191
  • Lilly USA, LLC$176
  • Bayer$115
  • plus $1K from 27 others

What the payments were for

  • Consulting fees$81722%
  • Food & beverage$2,82078%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,637 in reported general payments places this provider in the 80th percentile of 263 medical providers in Utah.

See all medical providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bupropion XlBupropion Hcl15$259
Rosuvastatin Calcium13$198
Topiramate16$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Upsher-smith Laboratories LLCTopiramate$12$6316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 263 medical providers in Utah.

Other medical in Millcreek

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →